Finally, the finding that GSTP1-positive prostate cancer subset is substantially over-represented among prostate cancers from Black compared to White men could be of importance from the standpoint of treatment of lethal prostate cancer, providing a potential biological underpinning, at least in part, for the observed disparate outcomes for Black men. This evidence concerns the gene GSTP1 and Familial prostate cancer.